6. CSP7 Inhibits p53 Expression and Improves Viability in AECs, and Mitigates Established Pulmonary Fibrosis in Human End-Stage IPF Lung Explants Treated Ex Vivo. Here, TP53 is linked to idiopathic pulmonary fibrosis.